Characterization of the Immune Response during Infection Caused by <i>Clostridioides difficile</i>

by Zohar Hamo, Maya Azrad, Orna Nitzan, Avi Peretz
Published 2019-10-01

Molecular Characterization and Moxifloxacin Susceptibility of <i>Clostridium difficile</i>

by Sarah Mizrahi, Zohar Hamo, Maya Azrad, Avi Peretz
Published 2019-08-01

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile

by Dana Binyamin, Dana Binyamin, Orna Nitzan, Orna Nitzan, Maya Azrad, Zohar Hamo, Zohar Hamo, Omry Koren, Avi Peretz, Avi Peretz
Published 2018-06-01

Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity of Clostridium difficile Infection

by Zohar Hamo, Zohar Hamo, Maya Azrad, Orna Nitzan, Orna Nitzan, Asaf Sagie, Linda Tkhawkho, Dana Binyamin, Dana Binyamin, Avi Peretz, Avi Peretz
Published 2017-12-01

IL-16 and BCA-1 Serum Levels Are Associated with Disease Severity of <i>C. difficile</i> Infection

by Dor Gotshal, Maya Azrad, Zohar Hamo, Orna Nitzan, Avi Peretz
Published 2021-05-01

The microbial diversity following antibiotic treatment of Clostridioides difficile infection

by Dana Binyamin, Orna Nitzan, Maya Azrad, Zohar Hamo, Omry Koren, Avi Peretz
Published 2021-04-01

Reduced Susceptibility to Chlorhexidine among <i>Staphylococcus aureus</i> Isolates in Israel: Phenotypic and Genotypic Tolerance

by Maya Azrad, Chen Shmuel, Tamar Leshem, Zohar Hamo, Moti Baum, Assaf Rokney, Keren Agay-Shay, Avi Peretz
Published 2021-03-01